Related Experiment Videos
The futility index. An approach to the cost-effective termination of randomized clinical trials
Abstract:
Although the randomized clinical trial is recognized as the method of choice for evaluating therapeutic innovations, it is often enormously expensive--in some instances, as a result of the unnecessary continuation of a trial destined to conclude that an innovation is not superior to standard therapy. Although most large clinical trials in which results evolve over time are monitored for early evidence of efficacy or toxicity, trials are rarely terminated because the probability of a positive result regarding the value of the innovation has become low. This paper discusses the issues involved in the monitoring and early termination of long-term clinical trials and describes the futility index, a probabilistic basis for early termination of trials of innovative therapy when the accumulated data imply small probability of success. Utilization of the futility index in the management of clinical trials of innovations can be of value in reducing, at slight loss of power, the number of unproductive studies carried to completion, thereby creating new opportunities for more effective use of limited resources.
Insights
This study introduces the futility index to stop costly clinical trials early when success is unlikely. This method helps conserve resources by avoiding unnecessary continuation of research with low probability of positive outcomes.
Area of Science:
- Clinical Trials
- Biostatistics
- Medical Research
Background:
- Randomized clinical trials are essential for evaluating new therapies but are often prohibitively expensive.
- Trials may continue unnecessarily even when data suggest the innovation is unlikely to prove superior.
Purpose of the Study:
- To discuss the challenges of monitoring and early termination in long-term clinical trials.
- To introduce the futility index as a probabilistic tool for early trial termination.
Main Methods:
- The paper reviews issues related to clinical trial monitoring and early termination.
- It describes the futility index, a statistical method for assessing the probability of a trial's success.
Main Results:
- The futility index provides a basis for terminating trials when accumulated data indicate a low probability of success.
- Early termination can reduce the number of unproductive studies completed.
Conclusions:
- Implementing the futility index can optimize resource allocation in clinical research.
- This approach can lead to more efficient use of limited resources by stopping unpromising trials early.